logo

FDA Calendar

Share
Company Name Nabriva Therapeutics
Drug Name CONTEPO (NDA)
Event Name FDA decision on CONTEPO IV for the treatment of complicated urinary tract infections
Event Date 04/30/2019
Outcome Date
Outcome FDA issues Complete Response Letter for CONTEPO IV on Apr 30
Drug Status Priority review
Rival Drugs
Market Potential
Other Approvals
News
Return to FDA Calendar